期刊文献+

益气化痰祛瘀方对冠心病大鼠一氧化氮和内皮素的影响 被引量:11

Effects of prescription Yiqi Huatan Quyu on No and ET contents of coronary heart disease rats
在线阅读 下载PDF
导出
摘要 目的观察益气化痰祛瘀方对冠心病大鼠血清一氧化氮(NO)和血浆内皮素(ET)的影响并探讨其机制。方法采用喂饲高脂饲料和腹腔注射脑垂体后叶素的方法复制冠心病大鼠模型,实验分组为正常组、模型组、复方丹参滴丸对照组、益气化痰祛瘀方高、低剂量组,施加相应药物干预后,测定各组大鼠血清NO和血浆ET含量。结果模型组大鼠NO含量较正常组明显降低(P<0.01),ET含量较正常组明显升高(P<0.01);与模型组比较,各用药组大鼠NO含量明显升高(P<0.05或P<0.01),ET含量明显降低(P<0.05或P<0.01);高、低剂量组在升高NO和降低ET方面均优于对照组(P<0.05)。结论益气化痰祛瘀方可能通过升高NO含量、降低ET含量,保护血管内皮功能,治疗冠心病。 Objective To observe the effects of prescription Yiqi Huatan Quyu on the NO content in the serum and ET content in the plasma of the coronary heart disease(CHD) rats and explore possible mechanism.Methods The model of CHD rats was established by feeding high fat forage and injecting pituitrin in the abdominal cavity.Then these rats were divided into normal,model,compound danshen drop pill control,high dose,low dose groups.Then NO content in the serum and ET content in the plasma were measured in all groups.Results NO content of model group was significantly reduced in comparison with that of normal group(P0.01).ET content of model group was significantly increased in comparison with that of normal group(P0.01).NO content increased remarkably(P0.05,P0.01) and ET content was much lower(P0.05,P0.01) of each treatment group in comparison with that of model group.The effect of increasing NO content and reducing ET content of high and low dose groups were much better than those of control group(P0.05).Conclusions Prescription Yiqi Huatan Quyu has the effect of increasing NO contents and reducing ET contents significantly.It could treat CHD by protecting vascular endothelial function.
机构地区 河北医科大学
出处 《中国老年学杂志》 CAS CSCD 北大核心 2011年第5期814-815,共2页 Chinese Journal of Gerontology
基金 河北省科技厅支撑计划课题(08276101D-37)
关键词 益气化痰祛瘀方 冠心病 大鼠 一氧化氮 内皮素 Prescription Yiqi Huatan Quyu CHD Rats NO ET
  • 相关文献

参考文献6

二级参考文献17

  • 1李中言,赵连友.一氧化氮与心血管疾病[J].中华心血管病杂志,1996,24(1):73-76. 被引量:81
  • 2时晶,田金洲,王永炎,朱爱华,尹军祥,武月萍,徐意.血瘀证的生物学基础研究[J].中华中医药杂志,2006,21(6):363-364. 被引量:85
  • 3HG沃格尔 WH沃格尔.药理学实验指南-新药发现和药理学评价[M].北京:科学出版社,2001.309-310.
  • 4Opie LH.Should calcium antagonist be used after myocardial infarction? Ischemia selectivity versus vascular selectivity[J].Cardiovasc Drugs Ther,1993,6(4):19 -24.
  • 5Fujimura Y,Tsuhoi H,Esato K.Efficacy of benidipine hydrochloride on myocardial ischemia and reperfusion[J].J Surg Res,1995,59(6):321 -325.
  • 6Yamashita T,Kawashima S,Ozaki M et al.A calcium channel blocker,benidipine,inhibits intimal thickening in the carotid artery of mice by increasing nitric oxide production[J].J Hypertens,2001,19(6) ;451 -458.
  • 7Karasawa A,Kubo K,Shuto K,et al.Pharmacological actions of benidipine hydrochloride in several isolated smooth muscles and myocardium[J].Arzneimittelforschung,1988,38 (5):1722 -1730.
  • 8Higo K,Karasawa A,Kubo K.Protective effects of benidipine hydrochloride (KW-3049),a calcium antagonist experimental arterial calainosis and endothelial dysfunction in rats[J].J Pharmacobiodyn,1992,15 (3):113.
  • 9Asanuma H,Kitakaze M,Node K,et al.Benidipine,a long-acting calcium channel blocker,limits infarct size via bradykinin and nodependent mechanisms in canine heart[J].Cardiovasc Drugs Ther,2001,15(7):225 -231.
  • 10Kojima M,Taninguchi M,Sato K,et al.Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days a randomized crossover trial between Benidipine and nifedipine[J].Nephron Clin Pract,2004,97 (2):49-53.

共引文献37

同被引文献158

引证文献11

二级引证文献130

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部